
Can the United States rebuild its pharmaceutical manufacturing industry with tariffs alone—or is a much broader strategy required? On this episode of Power Hour, Todd M. Schoenberger sits down with Kathleen Jaeger, U.S. Spokesperson for the Indian Pharmaceutical Alliance, to examine one of the most important public policy debates affecting healthcare, national security, and the economy. Kathleen explains why creating a resilient U.S. pharmaceutical supply chain requires more than imposing tariffs. Instead, she argues that America must reform its generic drug market, improve pricing transparency, strengthen domestic manufacturing, and deepen strategic partnerships with trusted allies like India. Kathleen also discusses the historic balance created by the 1984 Hatch-Waxman Act, explaining how today's pharmaceutical marketplace has shifted away from that original vision—and why policymakers have a limited window to enact meaningful reforms. As healthcare costs, supply chain resilience, and national security continue to dominate public policy discussions, this conversation offers timely insight into what it will take to secure America's medicine supply for decades to come. 🔗 Website: https://biztalktodaytv.com 📧 Contact on Email: support@biztalktodaytv.com 📲 Download the Biz Talk Today TV app on Apple & Android devices. 📢 Disclaimer: The views and opinions expressed on this program are those of the hosts and guests and do not necessarily reflect the official policy or position of CrossCheck Media Inc., Biz Talk Today TV (BTT), or their affiliated entities and distribution partners. Content produced by CrossCheck Media across video, audio, and digital platforms is provided for informational and educational purposes only. Nothing presented should be construed as financial, investment, legal, tax, or gambling advice, nor as a recommendation to buy or sell any security, asset, wager, or strategy. All investments and wagers involve risk, including the possible loss of principal or money placed on a bet. Past performance and statistical analysis are not indicative of future results. Viewers and readers are solely responsible for their financial and wagering decisions and should conduct their own due diligence and consult with qualified professionals where appropriate. Sports betting commentary is for informational and entertainment purposes only. Participants must comply with applicable laws and age requirements in their jurisdiction. #PowerHour #KathleenJaeger #GenericDrugs #Pharmaceuticals #DrugManufacturing #MedicineSecurity #Healthcare #SupplyChain #India #USIndia #APIs #PBMs #DrugPricing #HealthcarePolicy #NationalSecurity #Onshoring #Reshoring #GenericMedicine #BusinessNews #BizTalkTodayTV Learn more about your ad choices. Visit megaphone.fm/adchoices
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

NFL Futures Revealed & Can LeBron Deliver Philly a Championship? | Jared Smith & Michael K-B

LeBron's $4M Gamble Creates a $430M Sports Business Boom | Franchise Value

NFL Futures Revealed & Can LeBron Deliver Philly a Championship? | Jared Smith & Michael K-B

The Next Supercycle? Adam Patti on Space, Defense, Robotics & the Future of ETF Investing
Free AI-powered recaps of Biz Talk Today TV and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.